{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:12:27Z","timestamp":1790759547062,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1053\/j.jvca.2021.07.021","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T12:40:03Z","timestamp":1626439203000},"page":"1180-1187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Angiotensin II: A Review of Current Literature"],"prefix":"10.1053","volume":"36","author":[{"given":"Amit","family":"Alam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Sovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmeet","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"Ragula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gates B.","family":"Colbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Mooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2021.07.021_bib0001","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40256-018-0297-9","article-title":"FDA approval of angiotensin II for the treatment of hypotension in adults with distributive shock","volume":"19","author":"Senatore","year":"2019","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1053\/j.jvca.2021.07.021_bib0002","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ccc.2018.11.003","article-title":"Angiotensin II in Vasodilatory Shock","volume":"35","author":"Wakefield","year":"2019","journal-title":"Crit Care Clin"},{"key":"10.1053\/j.jvca.2021.07.021_bib0003","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jpainsymman.2016.12.333","article-title":"Intensity of Vasopressor Therapy For Septic Shock And The Risk Of In-Hospital Death","volume":"53","author":"Brand","year":"2017","journal-title":"J Pain Symptom"},{"key":"10.1053\/j.jvca.2021.07.021_bib0004","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2796.2008.01981.x","article-title":"Renin-angiotensin system revisited","volume":"264","author":"Fyhrquist","year":"2008","journal-title":"J Intern Med"},{"key":"10.1053\/j.jvca.2021.07.021_bib0005","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/CIRCULATIONAHA.107.728840","article-title":"Inotropes and vasopressors: Review of physiology and clinical use in cardiovascular disease","volume":"118","author":"Overgaard","year":"2008","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.07.021_bib0006","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1161\/CIR.0000000000000525","article-title":"Contemporary Management Of Cardiogenic Shock: A scientific statement from the American Heart Association","volume":"136","author":"van Diepen","year":"2017","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.07.021_bib0007","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2021.07.021_bib0008","first-page":"685","article-title":"Angiotensin II brings more questions than answers","volume":"43","author":"Farina","year":"2018","journal-title":"P T"},{"key":"10.1053\/j.jvca.2021.07.021_bib0009","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1177\/0885066620911601","article-title":"Angiotensin II and vasopressin for vasodilatory shock: A critical appraisal of catecholamine-sparing strategies","volume":"36","author":"Heavner","year":"2021","journal-title":"J Intensive Care Med"},{"key":"10.1053\/j.jvca.2021.07.021_bib0010","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/CIRCULATIONAHA.108.814533","article-title":"Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome","volume":"120","author":"Levin","year":"2009","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2021.07.021_bib0011","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s11748-017-0789-6","article-title":"Risk assessment and outcomes of vasoplegia after cardiac surgery","volume":"65","author":"Tsiouris","year":"2017","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2021.07.021_bib0012","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1365-2044.2006.04779.x","article-title":"Association between vasopressor dependence and early outcome in patients after cardiac surgery","volume":"61","author":"Weis","year":"2006","journal-title":"Anaesthesia"},{"key":"10.1053\/j.jvca.2021.07.021_bib0013","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1213\/00000539-199710000-00011","article-title":"The systemic inflammatory response to cardiopulmonary bypass: Pathophysiological, therapeutic, and pharmacological considerations","volume":"85","author":"Hall","year":"1997","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2021.07.021_bib0014","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0022-5223(98)70049-2","article-title":"Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agent","volume":"116","author":"Argenziano","year":"1998","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2021.07.021_bib0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1749-8090-5-17","article-title":"Perioperative infusion of low- dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting-A double-blind randomized study","volume":"5","author":"Papadopoulos","year":"2010","journal-title":"J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2021.07.021_bib0016","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/ALN.0000000000001434","article-title":"Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery: The VANCS randomized controlled trial","volume":"126","author":"Hajjar","year":"2017","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2021.07.021_bib0017","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.jvca.2020.08.001","article-title":"Treatment with angiotensin II Is associated with rapid blood pressure response and vasopressor sparing in patients with vasoplegia after cardiac surgery: A post-hoc analysis of angiotensin II for the treatment of high-output shock (ATHOS-3) Study","volume":"35","author":"Klijian","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2021.07.021_bib0018","first-page":"1095","article-title":"Hypotension as a risk factor for acute kidney injury in ICU patients","volume":"37","author":"Lehman","year":"2010","journal-title":"Comput Cardiol"},{"key":"10.1053\/j.jvca.2021.07.021_bib0019","doi-asserted-by":"crossref","first-page":"R181","DOI":"10.1186\/cc8167","article-title":"Association of arterial blood pressure and vasopressor load with septic shock mortality: A post hoc analysis of a multicenter trial","volume":"13","author":"D\u00fcnser","year":"2009","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2021.07.021_bib0020","doi-asserted-by":"crossref","first-page":"R135","DOI":"10.1186\/cc10253","article-title":"Relation between mean arterial pressure and renal function in the early phase of shock: A prospective, explorative cohort study","volume":"15","author":"Badin","year":"2011","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2021.07.021_bib0021","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.2147\/TCRM.S150434","article-title":"Angiotensin II: A new therapeutic option for vasodilatory shock","volume":"14","author":"Bussard","year":"2018","journal-title":"Ther Clin Risk Manag"},{"key":"10.1053\/j.jvca.2021.07.021_bib0022","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/CCM.0000000000003092","article-title":"Outcomes in patients with vasodilatory shock and renal replacement therapy treated with intravenous angiotensin II","volume":"46","author":"Tumlin","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2021.07.021_bib0023","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1097\/CCM.0000000000002441","article-title":"Clinical experience with IV angiotensin II administration: A systematic review of safety","volume":"45","author":"Busse","year":"2017","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2021.07.021_bib0024","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/0885066620972943","article-title":"A multicenter observational cohort study of angiotensin II in shock","volume":"37","author":"Smith","year":"2022","journal-title":"J Intensive Care Med"},{"key":"10.1053\/j.jvca.2021.07.021_bib0025","article-title":"Therapeutic strategies for high-dose vasopressor-dependent shock","volume":"2013","author":"Bassi","year":"2013","journal-title":"Crit Care Res Pract"},{"key":"10.1053\/j.jvca.2021.07.021_bib0026","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s13054-018-2144-4","article-title":"Refractory septic shock: Our pragmatic approach","volume":"22","author":"Nandhabalan","year":"2018","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2021.07.021_bib0027","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13054-020-2733-x","article-title":"Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock","volume":"24","author":"Bellomo","year":"2020","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2021.07.021_bib0028","article-title":"The Use of Angiotensin II for the Treatment of Post-cardiopulmonary Bypass Vasoplegia","author":"Papazisi","year":"2020","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1053\/j.jvca.2021.07.021_bib0029","article-title":"Angiotensin II for Critically Ill Patients With Shock After Heart Transplant","author":"Cutler","year":"2020","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2021.07.021_bib0030","doi-asserted-by":"crossref","first-page":"e912","DOI":"10.1097\/CCM.0000000000004502","article-title":"Use of angiotensin II in Severe vasoplegia after left pneumonectomy requiring cardiopulmonary bypass: A renin response analysis","volume":"48","author":"Trethowan","year":"2020","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2021.07.021_bib0031","doi-asserted-by":"crossref","first-page":"e01266","DOI":"10.1213\/XAA.0000000000001266","article-title":"Catecholamine-sparing effect of angiotensin II in an anephric patient with mixed shock after cardiac revascularization surgery: A case report","volume":"14","author":"Cutler","year":"2020","journal-title":"A A Pract"},{"key":"10.1053\/j.jvca.2021.07.021_bib0032","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jemermed.2019.05.027","article-title":"Successful treatment of antihypertensive overdose using intravenous angiotensin II","volume":"57","author":"Carpenter","year":"2019","journal-title":"J Emerg Med"},{"key":"10.1053\/j.jvca.2021.07.021_bib0033","unstructured":"U.S. National Library of Medicine - ClinicalTrials.gov. Angiotensin II Clinical Trials. Available at: https:\/\/clinicaltrials.gov\/ct2\/results?cond=&term=angiotensin+II&cntry=&state=&city=&dist=. Accessed March 30, 2021."},{"key":"10.1053\/j.jvca.2021.07.021_bib0034","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1164\/rccm.201911-2172OC","article-title":"Renin and survival in patients given angiotensin II for catecholamine-resistant vasodilatory shock. A clinical trial","volume":"202","author":"Bellomo","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.jvca.2021.07.021_bib0035","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1164\/rccm.202007-2731ED","article-title":"Renin, angiotensin II, and the journey to evidence-based individual treatment effects","volume":"202","author":"Casey","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.jvca.2021.07.021_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.CCM.0000105118.66983.19","volume":"32","author":"Bakker","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2021.07.021_bib0037","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.CCM.0000105581.01815.C6","article-title":"Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock","volume":"32","author":"L\u00f3pez","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2021.07.021_bib0038","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.chest.2020.08.2074","article-title":"Angiotensin II infusion for shock: A multicenter study of postmarketing use","volume":"159","author":"Wieruszewski","year":"2021","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2021.07.021_bib0039","doi-asserted-by":"crossref","DOI":"10.1053\/j.jvca.2021.04.005","article-title":"Underutilized fuel: Angiotensin II for vasoplegia in the heart failure patient population","author":"Alam","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077021006029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077021006029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T07:58:37Z","timestamp":1760947117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077021006029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1053077021006029"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2021.07.021","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin II: A Review of Current Literature","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2021.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}